ere’s what we’re looking out for this week in the worlds of pharma and biotech:

CRISPR goes to court

On Tuesday, the warring factions in the CRISPR patent dispute will make their cases to a panel of US Patent and Trademark Office judges in Alexandria, Va. At stake are millions of dollars in licensing fees — plus bragging rights to one of the biggest discoveries in recent science history. Sharon Begley, STAT’s senior science writer, will be there.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.